Both in Biotechnology
Lexeo Therapeutics vs Inhibikase Therapeutics
Over the past year LXEO returned −48.6% and IKT returned +32.0%; their daily moves had a correlation of 0.26.
LXEO −48.6% IKT +32.0%Growth of $1, one year, split-adjusted
| Metric | LXEO | IKT |
|---|---|---|
| Price | $3.42 | $2.02 |
| Market cap | $280.7M | $281.9M |
| Today | +8.92% | −1.46% |
| 1 month | −29.6% | −16.2% |
| 6 months | −35.1% | +27.8% |
| Year to date | −65.6% | −1.5% |
| 1 year | −49.5% | +30.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $211.1M | $159.0M |
| Dividend yield | — | — |
| Volatility (60d) | 63.4% | 49.7% |
| Short % of float | 28.2% | 17.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).